TheraRadar

Pharma Intelligence, Simplified

← All Targets

IL-6R

6 drugs
Immunology
Market Leader
ACTEMRA
Roche
7
approved indications
6
Approved Drugs
5
Companies
10
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (5 companies)
All 6 approved drugs
Therapeutic area breakdown
Full indication list (10 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Roche 2 drugs
Fresenius Kabi 1 drug
CELLTRION INC 1 drug

By Therapeutic Area

Immunology 4 drugs
Other 2 drugs